SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-23-281920
Filing Date
2023-11-22
Accepted
2023-11-22 09:20:57
Documents
8
Period of Report
2023-11-22

Document Format Files

Seq Description Document Type Size
1 6-K d53733d6k.htm 6-K 28016
2 EX-99.1 d53733dex991.htm EX-99.1 464407
3 EX-99.2 d53733dex992.htm EX-99.2 421242
4 EX-99.3 d53733dex993.htm EX-99.3 179156
5 EX-99.4 d53733dex994.htm EX-99.4 25365
6 GRAPHIC g53733dsp9.jpg GRAPHIC 4539
7 GRAPHIC g53733dsp99.jpg GRAPHIC 4407
8 GRAPHIC g53733g1122004435815.jpg GRAPHIC 2034
  Complete submission text file 0001193125-23-281920.txt   1134951
Mailing Address SYCAMORE HOUSE GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2BP
Business Address SYCAMORE HOUSE GUNNELS WOOD ROAD, STEVENAGE HERTFORDSHIRE X0 SG1 2BP 44 (0)1438 906870
Freeline Therapeutics Holdings plc (Filer) CIK: 0001810031 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39431 | Film No.: 231430122
SIC: 2836 Biological Products, (No Diagnostic Substances)